Research ArticleArticle
Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies
Margreet Kloppenburg, Pernille Bøyesen, A. Willemien Visser, Ida K. Haugen, Maarten Boers, Annelies Boonen, Philip G. Conaghan, Gillian A. Hawker, Tore K. Kvien, Robert Landewé, Till Uhlig, Wilma Smeets, Elsie Greibrokk and Désirée M. van der Heijde
The Journal of Rheumatology July 2015, jrheum.141017; DOI: https://doi.org/10.3899/jrheum.141017
Margreet Kloppenburg
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Pernille Bøyesen
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
A. Willemien Visser
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Ida K. Haugen
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Maarten Boers
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Annelies Boonen
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Philip G. Conaghan
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Gillian A. Hawker
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Tore K. Kvien
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Robert Landewé
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Till Uhlig
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Wilma Smeets
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Elsie Greibrokk
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Désirée M. van der Heijde
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center; CAPHRI Research Institute, Maastricht University, Maastricht, The Netherlands; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Women’s College Research Institute, Women’s College Hospital, and Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Departments of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam; Department of Rheumatology, Atrium Medical Center Heerlen, Heerlen, The Netherlands; National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. M. Kloppenburg, MD, PhD, Professor in Rheumatology, Department of Rheumatology, Leiden University Medical Center; P. Bøyesen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.W. Visser, MD, Department of Rheumatology, Leiden University Medical Center; I.K. Haugen, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; M. Boers, MSc, MD, PhD, Department of Epidemiology and Biostatistics, VU University Medical Center; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, and CAPHRI Research Institute, Maastricht University; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit; G.A. Hawker, MD, PhD, Women’s College Research Institute, Women’s College Hospital, University of Toronto; Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto; T.K. Kvien, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Departments of Rheumatology and Clinical Immunology, Academic Medical Center; Department of Rheumatology, Atrium Medical Center Heerlen; T. Uhlig, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital, National Advisory Unit on Rehabilitation in Rheumatology, Diakonhjemmet Hospital; W. Smeets, Department of Rheumatology, Leiden University Medical Center; E. Greibrokk, Department of Rheumatology, Diakonhjemmet Hospital; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Diakonhjemmet Hospital. Address correspondence to Dr. M. Kloppenburg, Postbox 9600, 2300 RC Leiden, The Netherlands; E-mail: g.kloppenburg@lumc.nl
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies
Margreet Kloppenburg, Pernille Bøyesen, A. Willemien Visser, Ida K. Haugen, Maarten Boers, Annelies Boonen, Philip G. Conaghan, Gillian A. Hawker, Tore K. Kvien, Robert Landewé, Till Uhlig, Wilma Smeets, Elsie Greibrokk, Désirée M. van der Heijde
The Journal of Rheumatology Jul 2015, jrheum.141017; DOI: 10.3899/jrheum.141017
Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies
Margreet Kloppenburg, Pernille Bøyesen, A. Willemien Visser, Ida K. Haugen, Maarten Boers, Annelies Boonen, Philip G. Conaghan, Gillian A. Hawker, Tore K. Kvien, Robert Landewé, Till Uhlig, Wilma Smeets, Elsie Greibrokk, Désirée M. van der Heijde
The Journal of Rheumatology Jul 2015, jrheum.141017; DOI: 10.3899/jrheum.141017